Global Ocular Drug Delivery Technology Market to be Worth US$18.1 Bn as Patients Prefer Targeted Ocular Drug Delivery
The global ocular drug delivery technology market is envisaged in a report by Transparency Market Research (TMR) to stay highly consolidated as top three players account for a substantial aggregate share. Close to a 50.0% share of the global ocular drug delivery technology market is secured by Santen Pharmaceutical Co., Ltd., Alimera Sciences, and Valeant Pharmaceuticals International, Inc. Nearly 14-18% share of the global ocular drug delivery technology market was collected by Alimera Sciences in 2016. The commercialization of EyePoint Pharmaceuticals-manufactured drug Iluvien played a significant part in helping Alimera attain the share. However, the other two of the top three companies dominate with their broad scope of ocular drugs.
TMR predicts the global ocular drug delivery technology market to rise at a 6.28% CAGR for the forecast period 2017-2025 to obtain a valuation of US$18.1 bn by the final forecast year. In 2016, the global ocular drug delivery technology market was valued at a US$10.2 bn. Among technologies, topical is anticipated to dominate the global ocular drug delivery technology market as it rises at a 6.6% CAGR. Regionally, North America could take a leading position in the global ocular drug delivery technology market, considering its 52.5% share achieved in 2016.
Increasing Instances of Macular Degeneration and Glaucoma to Push Demand
The global ocular drug delivery technology market is projected to increase growth on the back of the rising patient preference for targeted drug delivery techniques. Increase in the number of glaucoma and macular degeneration cases could set the tone for consistent demand in the global ocular drug delivery technology market. Rising FDA approvals for new and advanced drug delivery techniques are expected to push the growth of the global ocular drug delivery technology market. Lack of bioavailability of different drugs in conventional ocular therapies could augur well for the global ocular drug delivery technology market.
Ocular Inserts and Implants Causing Discomfort to Patients Discourage Adoption
Discomfort is one factor that could negatively hamper the demand in the global ocular drug delivery technology market. Apart from being uncomfortable, the process of ocular drug delivery can cause high lachrymation, irritation, and dilution due to the hardness of the implants. The idea of foreign body penetration in the eyes also makes patients uncomfortable, thus placing a negative impact on the global ocular drug delivery technology market.
However, the availability of a strong pipeline of drugs and other treatment products in the ophthalmic sector is envisioned to create profit-making opportunities in the global ocular drug delivery technology market. Increasing collaboration between vendors and hospitals could open the door for new opportunities in the global ocular drug delivery technology market.
The information presented in this review is based on a TMR report, titled “Ocular Drug Delivery Technology Market (Technology - Topical, Ocular Inserts (Non-erodible and Erodible), Iontophoresis, Intraocular Implants (Biodegradable and Non-biodegradable), and In Situ Gels and Punctal Plugs; Formulation - Suspension, Solution, Emulsion, Liposomes and Nanoparticles, and Ointments; Disease - Glaucoma, Diabetic Retinopathy, Macular Degeneration, Diabetic Macular Edema, Dry Eye Syndrome, and Cataract; End User - Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, and Homecare Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.”
The global ocular drug delivery technology market has been segmented as presented below:
Global Ocular Drug Delivery Technology Market by Technology
- Ocular Inserts
- Intraocular Implants
- In Situ Gel and Punctal Plugs
Global Ocular Drug Delivery Technology Market by Formulation
- Liposomes and Nanoparticles
Global Ocular Drug Delivery Technology Market by Disease
- Macular Degeneration
- Diabetic Retinopathy
- Diabetic Macular Edema
- Dry Eye Syndrome
Global Ocular Drug Delivery Technology Market by End User
- Ambulatory Surgical Centers
- Ophthalmic Clinics
- Homecare Settings
Global Ocular Drug Delivery Technology Market by Region
- North America
- Rest of Europe
- Asia Pacific
- Australia and New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
7 of 10 large enterprizes view our ToC to take the right decision.View Report ToC